Abstract
Over-expression of matrix metalloproteinase 9(MPP 9) in brain could degrade extracellular matrix, destroy the structure of microvascular basal membrane and vascular wall, take part in neural- inflammatory response in a rat model of cardiopulmonary resuscitation (CPR). SB-3CT is a antagonist of MPP 9. SB-3CT can inhibit over-expression of MPP 9 and reduce impairment of brain in a rat model of CPR. One hundred and twenty rats were randomly divided into 3 groups: the sham-operated group, the resuscitation control group and the resuscitation treatment group with SB-3CT. The rats were executed and the brains were taken out at 0h, 3h, 9h, 24h and 48h. The expression of MMP 9 in brain was detected. Water content and Evans blue content in brain tissue were observed. The expression of MMP 9 (Table 1 ), water content and Evans blue content in the resuscitation control group was obviously higher than the sham-operated group at 0h, 3h, 9h, 24h and 48h. The expression of MMP 9, water content and Evans blue content in the resuscitation treatment group was similar to the resuscitation control group at different time, but the level was lower than the resuscitation control group(p<0.05). SB-3CT as a specific antagonist of MMP9, could decrease the expression of MMP9 and decrease cerebral edema in a rat model of CPR, and it may be a useful traetment method for cerebral ischemia/reperfusion injury after CPR. Table 1 Expression of brain MMP 9 after resuscitation in a rat model of CPR
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
